Galaxy Surfactants Intrinsic Value
GALAXYSURF • Chemicals
Current Stock Price
₹1677.80
Primary Intrinsic Value
₹900.00
Market Cap
₹6040 Cr
-46.8%
Downside
Median Value
₹893.33
Value Range
₹503 - ₹1184
Assessment
Trading Above Calculated Value
Safety Margin
-87.8%
GALAXYSURF Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹900.00 | ₹720.00 - ₹1080.00 | -46.4% | EPS: ₹75.00, Sector P/E: 12x |
| Book Value Method | asset | ₹656.39 | ₹590.75 - ₹722.03 | -60.9% | Book Value/Share: ₹656.39, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1184.00 | ₹1065.60 - ₹1302.40 | -29.4% | Revenue/Share: ₹1480.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹773.33 | ₹696.00 - ₹850.66 | -53.9% | EBITDA: ₹464.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1029.09 | ₹823.27 - ₹1234.91 | -38.7% | CF Growth: 3.6%, Discount: 15% |
| PEG Ratio Method | growth | ₹503.34 | ₹453.01 - ₹553.67 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹618.00 | ₹556.20 - ₹679.80 | -63.2% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹893.33 | ₹804.00 - ₹982.66 | -46.8% | ROE: 11.3%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹1052.45 | ₹947.21 - ₹1157.70 | -37.3% | EPS: ₹75.00, BVPS: ₹656.39 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
GALAXYSURF Intrinsic Value Analysis
What is the intrinsic value of GALAXYSURF?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Galaxy Surfactants (GALAXYSURF) is ₹893.33 (median value). With the current market price of ₹1677.80, this represents a -46.8% variance from our estimated fair value.
The valuation range spans from ₹503.34 to ₹1184.00, indicating ₹503.34 - ₹1184.00.
Is GALAXYSURF undervalued or overvalued?
Based on our multi-method analysis, Galaxy Surfactants (GALAXYSURF) appears to be trading above calculated value by approximately 46.8%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 17.31 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 11.3% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.54x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Galaxy Surfactants
Additional stock information and data for GALAXYSURF
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹421 Cr | ₹276 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹518 Cr | ₹348 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹573 Cr | ₹503 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹5 Cr | ₹-36 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹365 Cr | ₹282 Cr | Positive Free Cash Flow | 8/10 |